Related Articles
Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients
Baseline lymphopenia as prognostic factor in patients with metastatic breast cancer treated with palbociclib
Fatty acid synthase activity regulates HER2 extracellular domain shedding into the circulation of HER2-positive metastatic breast cancer patients
Long‑responders to anti‑HER2 therapies: A case report and review of the literature